These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8003924)

  • 41. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.
    Tota S; Nath C; Najmi AK; Shukla R; Hanif K
    Behav Brain Res; 2012 Jun; 232(1):66-76. PubMed ID: 22460064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission.
    Fontana DJ; Inouye GT; Johnson RM
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1075-82. PubMed ID: 7886078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice.
    Botton PH; Costa MS; Ardais AP; Mioranzza S; Souza DO; da Rocha JB; Porciúncula LO
    Behav Brain Res; 2010 Dec; 214(2):254-9. PubMed ID: 20553765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation of benzodiazepine-induced passive avoidance deficit by post-training administration of muscimol: interaction with the cholinergic neuronal system.
    Nabeshima T; Tohyama K; Ichihara K; Kameyama T
    Eur J Pharmacol; 1990 Jul; 182(3):555-60. PubMed ID: 1977593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of minaprine on cycloheximide-induced amnesia in mice.
    Nabeshima T; Kawashima K; Kameyama T
    Eur J Pharmacol; 1989 Oct; 169(2-3):249-57. PubMed ID: 2530096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
    Mansouri MT; Farbood Y; Naghizadeh B; Shabani S; Mirshekar MA; Sarkaki A
    Pharm Biol; 2016 Oct; 54(10):1947-53. PubMed ID: 26828763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-amnesic effect of Ficus religiosa in scopolamine-induced anterograde and retrograde amnesia.
    Kaur H; Singh D; Singh B; Goel RK
    Pharm Biol; 2010 Feb; 48(2):234-40. PubMed ID: 20645848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Jen-San-Yaung-Jung-Tang on scopolamine-induced amnesia in rats.
    Lu MC
    Am J Chin Med; 1998; 26(2):117-25. PubMed ID: 9799963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice.
    Wang SY; Wang HH; Chi CW; Chen CF; Liao JF
    Eur J Pharmacol; 2004 Dec; 506(1):55-61. PubMed ID: 15588624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of scopolamine on activity and passive avoidance learning in rats of different ages.
    Feigley DA
    J Comp Physiol Psychol; 1974 Jul; 87(1):26-36. PubMed ID: 4413163
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems.
    Ishihara S; Hiramatsu M; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1993 Jan; 230(3):313-20. PubMed ID: 8382617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
    Suzuki F; Shimada J; Shiozaki S; Ichikawa S; Ishii A; Nakamura J; Nonaka H; Kobayashi H; Fuse E
    J Med Chem; 1993 Aug; 36(17):2508-18. PubMed ID: 8355252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebral activating properties of indeloxazine hydrochloride.
    Yamamoto M; Shimizu M
    Neuropharmacology; 1987 Jul; 26(7A):761-70. PubMed ID: 3627384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia.
    Evenden JL; Lavis L; Iversen SD
    Psychopharmacology (Berl); 1992; 106(2):179-88. PubMed ID: 1312728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Negative and positive effects of intracerebroventricular scopolamine on memory in mice undergoing passive avoidance and escape tests.
    Nakajima M; Inui A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
    Brain Res Bull; 1994; 34(4):375-80. PubMed ID: 8082028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus.
    Zarrindast MR; Ardjmand A; Ahmadi S; Rezayof A
    Behav Brain Res; 2012 Apr; 229(1):68-73. PubMed ID: 22226623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amnesic effects of scopolamine.
    Glick SD; Zimmerberg B
    Behav Biol; 1972 Apr; 7(2):245-54. PubMed ID: 5064951
    [No Abstract]   [Full Text] [Related]  

  • 58. Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice.
    Lee KY; Sung SH; Kim SH; Jang YP; Oh TH; Kim YC
    Arch Pharm Res; 2009 May; 32(5):677-83. PubMed ID: 19471881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice.
    Khalifa AE
    J Ethnopharmacol; 2001 Jun; 76(1):49-57. PubMed ID: 11378281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strength of scopolamine-induced amnesia as a function of time between training and testing.
    Quartermain D; Leo P
    Behav Neural Biol; 1988 Nov; 50(3):300-10. PubMed ID: 3202813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.